CoChat

Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy

Open access
Kim, Jang Keun, Cho, Jun, Kim, Se Hoon, Kang, Hoon-Chul, Kim, Dong-Seok, Kim, V. Narry, Lee, Jeong Ho · 2019 · Journal of Clinical Investigation
Cited by 66

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

10).Interestingly, somatic activating mutations in MTOR with low mutational burden (e.g., mutated allele frequency of ~1% in the affected tissue) have been shown to be sufficient to lead to intractable focal epilepsy (4).The molecular mechanism of how somatic activating mutations in MTOR cause intractable epilepsy, however, has remained elusive.mTOR kinase is a major regulator of translation, which is a fundamental molecular mechanism regulating gene expression (11).Translational dysregulation is thought to underlie the molecular pathogenesis of various human diseases, particularly cancers and neurodevelopmental disorders, as they are associated with the aberrant activation of mTOR (11,12).Accordingly, we hypothesized that translational dysregulation induced by human MTOR mutations may underlie the molecular pathogenesis of intractable epilepsy and other pathologies found in FMCD.However, owing to a lack of disease models of single activating mutations in MTOR, we found understanding of the molecular basis of translational dysregulation directly induced by human MTOR mutations to be lacking: previous studies of mTOR-driven translational control have relied on pharmacological inhibition of mTOR (13, 14).To date, translational profiles in disease models with single MTOR mutations are not available, and questions of how human MTOR mutations lead to disease, which genes are controlled, and how they are regulated remain largely unanswered.In this study using FMCD mouse models, genome-edited cells, and patient brain Brain somatic mutations confer genomic diversity in the human brain and cause neurodevelopmental disorders.Recently, brain somatic activating mutations in MTOR have been identified as a major etiology of intractable epilepsy in patients with cortical malformations.However, the molecular genetic mechanism of how brain somatic mutations in MTOR cause intractable epilepsy has remained elusive.In this study, translational profiling of intractable epilepsy mouse models with brain somatic mutations and genome-edited cells revealed a novel translational dysregulation mechanism and mTOR activation-sensitive targets mediated by human MTOR mutations that lead to intractable epilepsy with cortical malformation.These mTOR targets were found to be regulated by novel mTOR-responsive 5′-UTR motifs, distinct from known mTOR inhibition-sensitive targets regulated by 5′ terminal oligopyrimidine motifs.Novel mTOR target genes were validated in patient brain tissues, and the mTOR downstream effector eIF4E was identified as a new therapeutic target in intractable epilepsy via pharmacological or genetic inhibition.We show that metformin, an FDA-approved eIF4E inhibitor, suppresses intractable epilepsy.Altogether, the present study describes translational dysregulation resulting from brain somatic mutations in MTOR, as well as the pathogenesis and potential therapeutic targets of intractable epilepsy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci127032

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 66

Metadata

Authors
Kim, J. K., Cho, J., Kim, S. H., Kang, H.-C., Kim, D.-S., Kim, V. N., & Lee, J. H.
Venue
Journal of Clinical Investigation
Published
2019-09-04
Volume
129
Issue
10
Pages
4207-4223
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2972471297
Cited by
66
References
12
FWCI
5.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy. https://app.cochat.ai/papers/10.1172/jci127032
The paper
Kim, J. K., Cho, J., Kim, S. H., Kang, H.-C., Kim, D.-S., Kim, V. N., & Lee, J. H. (2019). Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy. Journal of Clinical Investigation. https://doi.org/10.1172/jci127032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.